documents: FDA-2008-P-0343-0022
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | agency_id | docket_id | title | document_type | subtype | posted_date | posted_year | posted_month | comment_start_date | comment_end_date | last_modified | fr_doc_num | open_for_comment | withdrawn | object_id |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FDA-2008-P-0343-0022 | FDA | FDA-2008-P-0343 | Exhibit 2 - "Winston & Strawn LLP (on behalf of Caraco) to FDA/CDER, re: request for Correction, June 1, 2009" - [Caraco Pharmaceuticals Laboratories, LTD - (Winston & Strawn LLP) - Reply Comment] re FDA-2008-P-0343-0020 | Supporting & Related Material | RC-Reply Comment (Supporting and Related Material) | 2009-06-17T04:00:00Z | 2009 | 6 | 2009-06-18T00:17:05Z | 0 | 0 | 09000064809d01f3 |
Links from other tables
- 0 rows from regs_document_id in fr_regs_crossref